sb 203580 has been researched along with Cacosmia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, X; Li, N; Zhang, J | 1 |
1 other study(ies) available for sb 203580 and Cacosmia
Article | Year |
---|---|
SB203580, a p38MAPK inhibitor, attenuates olfactory dysfunction by inhibiting OSN apoptosis in AR mice (activation and involvement of the p38 mitogen-activated protein kinase in olfactory sensory neuronal apoptosis of OVA-induced allergic rhinitis).
Topics: Animals; Apoptosis; Female; Imidazoles; Irritants; MAP Kinase Signaling System; Mice, Inbred BALB C; Olfaction Disorders; Olfactory Receptor Neurons; Ovalbumin; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Rhinitis, Allergic; Signal Transduction; Smell | 2019 |